Skip to content

Clinical Study on the Treatment of Polycystic Ovary Syndrome with Kidney Deficiency and Blood Stasis Type Infertility Using You's Four-Phase Conception Method

Clinical Study on the Treatment of Polycystic Ovary Syndrome with Kidney Deficiency and Blood Stasis Type Infertility Using You's Four-Phase Conception Method

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000250
Enrollment
Unknown
Registered
2025-02-13
Start date
2025-02-28
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic Ovary Syndrome

Interventions

Treatment Group:Four-Phase Fertility Prep:1) Days 1-6: You's Tiaojing Formula, 1 dose/day, split into 2.2) Days 7-16: Switch to You's Zhuluan Formula, same admin.3) Days 11-14: B-ultrasound for ovulat
Control Group:Starting from the fifth day of menstruation, take oral Letrozole 5mg per time , once a day, at 8 pm, for five consecutive days. Use B-ultrasound to monitor ovulation and arrange intercou

Sponsors

-
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: (1) Female patients aged between 18 and 40 years (inclusive) with fertility needs; (2) Patients diagnosed with PCOS infertility according to Western medicine and with a Traditional Chinese Medicine syndrome diagnosis of kidney deficiency and blood stasis; (3) All patients voluntarily sign an informed consent form.

Exclusion criteria

Exclusion criteria: (1) Patients allergic to traditional Chinese medicine letrozole or first-line ovulation induction drugs; (2) Patients with other causes of hyperandrogenism excluded (e.g. congenital adrenal hyperplasia Cushing's syndrome androgen-secreting tumors 21-hydroxylase deficiency non-classic adrenal hyperplasia exogenous androgen use etc.); (3) Patients with endocrine diseases causing ovulatory disorders such as premature ovarian failure hyperprolactinemia functional hypothalamic amenorrhea thyroid dysfunction etc.; (4) Patients with reproductive organ lesions such as endometriosis adenomyosis or uterine fibroids

Design outcomes

Primary

MeasureTime frame
Pregnancy rate;

Secondary

MeasureTime frame
FPG;Six types of sex hormones;LDL-C;ovulation rate;FINS;TC;Traditional Chinese Medicine Syndrome Score;acne;HDL-C;TG;

Countries

China

Contacts

Public Contact-

-

liuwene@163.com+86 135 7487 2658

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026